Treatment outcome of radiotherapy for primary ocular adnexal MALT lymphoma

Saiji Ohga, K. Nakamura, Y. Shioyama, T. Sasaki, T. Yamaguchi, T. Toba, T. Yoshitake, H. Honda, H. Terashima, H. Yoshikawa

Research output: Contribution to journalArticlepeer-review


Between February 1995 and September 2004, 47 patients (53 lesions) with primary ocular adnexal MALT lymphoma were treated with radiotherapy. The median dose delivered was 30Gy/20F. Lens shielding was used in 11 patients. Local control rate was 98%. 3, 5 years OAS (overall survival) and RFS (relapse-free survival) were 100%. 100% and 100%, 88%. respectively. Cataracts developed in 17%. Radiotherapy achieved excellent local control and survival rates in the management of primary ocular adnexal MALT lymphoma. Late adverse effects were tolerable.

Original languageEnglish
Pages (from-to)1794-1797
Number of pages4
JournalJapanese Journal of Clinical Radiology
Issue number13
Publication statusPublished - 2005

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Treatment outcome of radiotherapy for primary ocular adnexal MALT lymphoma'. Together they form a unique fingerprint.

Cite this